Merck appoints Wolfgang Büchele as Supervisory Board Chairman

12 May 2014
merck-serono-big

The newly appointed Supervisory Board of Merck has elected at its inaugural meeting Wolfgang Büchele as the Chairman of this corporate governance body. Before that, the Annual General Meeting had elected the eight shareholder representatives.

The eight employee representative members of the Supervisory Board had already been elected in April. The term of office of the previous Supervisory Board members expired upon conclusion of the Annual General Meeting. The new term of office runs until the conclusion of the Annual General Meeting that will resolve on the approval of the actions of the Executive Board for fiscal 2018.

At today's Annual General Meeting, the shareholders also approved the increase of €0.20 in the dividend to €1.90, which corresponds to a total dividend payment of approximately €413 million and a payout ratio of around 31%. Shareholders also voted in favour of the proposed 2:1 share split.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical